Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Rhea-AI Summary
Perrigo (NYSE:PRGO) announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on June 9, 2026, at 10:30 AM EDT.
The presentation webcast will be accessible via Perrigo's investor relations website.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – PRGO
On the day this news was published, PRGO declined 3.74%, reflecting a moderate negative market reaction. Argus tracked a trough of -5.7% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $61M from the company's valuation, bringing the market cap to $1.57B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
PRGO was down 1.15% pre-news. Several peers were also softer (PBH -0.39%, AMRX -0.36%, BHC -0.27%, HCM -0.08%), while INDV rose 0.70%. Scanner data did not flag a coordinated sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 06 | Q1 2026 earnings | Negative | +5.3% | Soft sales and large goodwill impairment but shares rose afterward. |
| Apr 30 | Asset divestiture | Positive | +0.7% | Dermacosmetics sale to reduce debt and strengthen balance sheet. |
| Apr 29 | Dividend declaration | Positive | -1.9% | Quarterly cash dividend of $0.29 per share announced. |
| Apr 22 | Earnings date notice | Neutral | -0.2% | Scheduled Q1 2026 results release and conference call details. |
| Mar 03 | Conference presentation | Neutral | +2.6% | UBS conference appearance outlining consumer health strategy. |
Mixed reactions: strategic and conference updates have tended to see modest gains, while dividend and some neutral notices saw slight declines. A weak fundamental quarter with impairment previously coincided with a positive price reaction.
Over recent months, Perrigo has balanced portfolio reshaping, capital returns, and investor outreach. Q1 2026 results showed core net sales of $842M, down 8.3% year-over-year with a reported diluted EPS of $(2.81) driven by a $330.8M goodwill impairment, yet the stock rose 5.33%. The company completed the Dermacosmetics divestiture for up to €332.6M, mainly for debt reduction, and maintained a quarterly dividend of $0.29 per share. Investor conference appearances, like the UBS event on March 11, 2026, previously coincided with modest gains.
Market Pulse Summary
This announcement highlights Perrigo’s continued investor outreach, with the CEO and CFO presenting at a major consumer and e-commerce conference on June 9 at 10:30 AM EDT. It reinforces the company’s positioning as a pure-play consumer health provider with over a century of experience in OTC self-care. Against recent developments—portfolio divestitures, ongoing dividends, and a challenged quarter—investors may focus on any strategic updates or longer-term outlook shared during the presentation.
Key Terms
over-the-counter (otc) medical
forward-looking statements regulatory
form 10-k regulatory
AI-generated analysis. Not financial advice.
Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
About Perrigo
Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's presentation at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contact
Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375, eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238, nicholas.gallagher@perrigo.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-present-at-the-oppenheimer-26th-annual-consumer-growth--e-commerce-conference-302781685.html
SOURCE Perrigo Company plc